Pre-order Enquiry
Request Free Sample
Global Cyclooxygenase 2 Inhibitor Market Size, Status and Forecast 2021-2027
SKU ID : QYR-17717343 | Publishing Date : 18-Mar-2021 | No. of pages : 108
Detailed TOC of Global Cyclooxygenase 2 Inhibitor Market Size, Status and Forecast 2021-2027
1 Report Overview1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cyclooxygenase 2 Inhibitor Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Selective Cox 2 Inhibitor
1.2.3 Non-Selective Cox 2 Inhibitor
1.3 Market by Application
1.3.1 Global Cyclooxygenase 2 Inhibitor Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Specialty Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cyclooxygenase 2 Inhibitor Market Perspective (2016-2027)
2.2 Cyclooxygenase 2 Inhibitor Growth Trends by Regions
2.2.1 Cyclooxygenase 2 Inhibitor Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Cyclooxygenase 2 Inhibitor Historic Market Share by Regions (2016-2021)
2.2.3 Cyclooxygenase 2 Inhibitor Forecasted Market Size by Regions (2022-2027)
2.3 Cyclooxygenase 2 Inhibitor Industry Dynamic
2.3.1 Cyclooxygenase 2 Inhibitor Market Trends
2.3.2 Cyclooxygenase 2 Inhibitor Market Drivers
2.3.3 Cyclooxygenase 2 Inhibitor Market Challenges
2.3.4 Cyclooxygenase 2 Inhibitor Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cyclooxygenase 2 Inhibitor Players by Revenue
3.1.1 Global Top Cyclooxygenase 2 Inhibitor Players by Revenue (2016-2021)
3.1.2 Global Cyclooxygenase 2 Inhibitor Revenue Market Share by Players (2016-2021)
3.2 Global Cyclooxygenase 2 Inhibitor Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Cyclooxygenase 2 Inhibitor Revenue
3.4 Global Cyclooxygenase 2 Inhibitor Market Concentration Ratio
3.4.1 Global Cyclooxygenase 2 Inhibitor Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cyclooxygenase 2 Inhibitor Revenue in 2020
3.5 Cyclooxygenase 2 Inhibitor Key Players Head office and Area Served
3.6 Key Players Cyclooxygenase 2 Inhibitor Product Solution and Service
3.7 Date of Enter into Cyclooxygenase 2 Inhibitor Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cyclooxygenase 2 Inhibitor Breakdown Data by Type
4.1 Global Cyclooxygenase 2 Inhibitor Historic Market Size by Type (2016-2021)
4.2 Global Cyclooxygenase 2 Inhibitor Forecasted Market Size by Type (2022-2027)
5 Cyclooxygenase 2 Inhibitor Breakdown Data by Application
5.1 Global Cyclooxygenase 2 Inhibitor Historic Market Size by Application (2016-2021)
5.2 Global Cyclooxygenase 2 Inhibitor Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Cyclooxygenase 2 Inhibitor Market Size (2016-2027)
6.2 North America Cyclooxygenase 2 Inhibitor Market Size by Type
6.2.1 North America Cyclooxygenase 2 Inhibitor Market Size by Type (2016-2021)
6.2.2 North America Cyclooxygenase 2 Inhibitor Market Size by Type (2022-2027)
6.2.3 North America Cyclooxygenase 2 Inhibitor Market Size by Type (2016-2027)
6.3 North America Cyclooxygenase 2 Inhibitor Market Size by Application
6.3.1 North America Cyclooxygenase 2 Inhibitor Market Size by Application (2016-2021)
6.3.2 North America Cyclooxygenase 2 Inhibitor Market Size by Application (2022-2027)
6.3.3 North America Cyclooxygenase 2 Inhibitor Market Size by Application (2016-2027)
6.4 North America Cyclooxygenase 2 Inhibitor Market Size by Country
6.4.1 North America Cyclooxygenase 2 Inhibitor Market Size by Country (2016-2021)
6.4.2 North America Cyclooxygenase 2 Inhibitor Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Cyclooxygenase 2 Inhibitor Market Size (2016-2027)
7.2 Europe Cyclooxygenase 2 Inhibitor Market Size by Type
7.2.1 Europe Cyclooxygenase 2 Inhibitor Market Size by Type (2016-2021)
7.2.2 Europe Cyclooxygenase 2 Inhibitor Market Size by Type (2022-2027)
7.2.3 Europe Cyclooxygenase 2 Inhibitor Market Size by Type (2016-2027)
7.3 Europe Cyclooxygenase 2 Inhibitor Market Size by Application
7.3.1 Europe Cyclooxygenase 2 Inhibitor Market Size by Application (2016-2021)
7.3.2 Europe Cyclooxygenase 2 Inhibitor Market Size by Application (2022-2027)
7.3.3 Europe Cyclooxygenase 2 Inhibitor Market Size by Application (2016-2027)
7.4 Europe Cyclooxygenase 2 Inhibitor Market Size by Country
7.4.1 Europe Cyclooxygenase 2 Inhibitor Market Size by Country (2016-2021)
7.4.2 Europe Cyclooxygenase 2 Inhibitor Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Cyclooxygenase 2 Inhibitor Market Size (2016-2027)
8.2 Asia-Pacific Cyclooxygenase 2 Inhibitor Market Size by Type
8.2.1 Asia-Pacific Cyclooxygenase 2 Inhibitor Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Cyclooxygenase 2 Inhibitor Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Cyclooxygenase 2 Inhibitor Market Size by Type (2016-2027)
8.3 Asia-Pacific Cyclooxygenase 2 Inhibitor Market Size by Application
8.3.1 Asia-Pacific Cyclooxygenase 2 Inhibitor Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Cyclooxygenase 2 Inhibitor Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Cyclooxygenase 2 Inhibitor Market Size by Application (2016-2027)
8.4 Asia-Pacific Cyclooxygenase 2 Inhibitor Market Size by Region
8.4.1 Asia-Pacific Cyclooxygenase 2 Inhibitor Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Cyclooxygenase 2 Inhibitor Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Cyclooxygenase 2 Inhibitor Market Size (2016-2027)
9.2 Latin America Cyclooxygenase 2 Inhibitor Market Size by Type
9.2.1 Latin America Cyclooxygenase 2 Inhibitor Market Size by Type (2016-2021)
9.2.2 Latin America Cyclooxygenase 2 Inhibitor Market Size by Type (2022-2027)
9.2.3 Latin America Cyclooxygenase 2 Inhibitor Market Size by Type (2016-2027)
9.3 Latin America Cyclooxygenase 2 Inhibitor Market Size by Application
9.3.1 Latin America Cyclooxygenase 2 Inhibitor Market Size by Application (2016-2021)
9.3.2 Latin America Cyclooxygenase 2 Inhibitor Market Size by Application (2022-2027)
9.3.3 Latin America Cyclooxygenase 2 Inhibitor Market Size by Application (2016-2027)
9.4 Latin America Cyclooxygenase 2 Inhibitor Market Size by Country
9.4.1 Latin America Cyclooxygenase 2 Inhibitor Market Size by Country (2016-2021)
9.4.2 Latin America Cyclooxygenase 2 Inhibitor Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cyclooxygenase 2 Inhibitor Market Size (2016-2027)
10.2 Middle East & Africa Cyclooxygenase 2 Inhibitor Market Size by Type
10.2.1 Middle East & Africa Cyclooxygenase 2 Inhibitor Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Cyclooxygenase 2 Inhibitor Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Cyclooxygenase 2 Inhibitor Market Size by Type (2016-2027)
10.3 Middle East & Africa Cyclooxygenase 2 Inhibitor Market Size by Application
10.3.1 Middle East & Africa Cyclooxygenase 2 Inhibitor Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Cyclooxygenase 2 Inhibitor Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Cyclooxygenase 2 Inhibitor Market Size by Application (2016-2027)
10.4 Middle East & Africa Cyclooxygenase 2 Inhibitor Market Size by Country
10.4.1 Middle East & Africa Cyclooxygenase 2 Inhibitor Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Cyclooxygenase 2 Inhibitor Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Cyclooxygenase 2 Inhibitor Introduction
11.1.4 Pfizer Revenue in Cyclooxygenase 2 Inhibitor Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Bayer
11.2.1 Bayer Company Details
11.2.2 Bayer Business Overview
11.2.3 Bayer Cyclooxygenase 2 Inhibitor Introduction
11.2.4 Bayer Revenue in Cyclooxygenase 2 Inhibitor Business (2016-2021)
11.2.5 Bayer Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Cyclooxygenase 2 Inhibitor Introduction
11.3.4 Novartis Revenue in Cyclooxygenase 2 Inhibitor Business (2016-2021)
11.3.5 Novartis Recent Development
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview
11.4.3 Merck Cyclooxygenase 2 Inhibitor Introduction
11.4.4 Merck Revenue in Cyclooxygenase 2 Inhibitor Business (2016-2021)
11.4.5 Merck Recent Development
11.5 Sabinsa
11.5.1 Sabinsa Company Details
11.5.2 Sabinsa Business Overview
11.5.3 Sabinsa Cyclooxygenase 2 Inhibitor Introduction
11.5.4 Sabinsa Revenue in Cyclooxygenase 2 Inhibitor Business (2016-2021)
11.5.5 Sabinsa Recent Development
11.6 Cadila Pharmaceuticals
11.6.1 Cadila Pharmaceuticals Company Details
11.6.2 Cadila Pharmaceuticals Business Overview
11.6.3 Cadila Pharmaceuticals Cyclooxygenase 2 Inhibitor Introduction
11.6.4 Cadila Pharmaceuticals Revenue in Cyclooxygenase 2 Inhibitor Business (2016-2021)
11.6.5 Cadila Pharmaceuticals Recent Development
11.7 Mylan
11.7.1 Mylan Company Details
11.7.2 Mylan Business Overview
11.7.3 Mylan Cyclooxygenase 2 Inhibitor Introduction
11.7.4 Mylan Revenue in Cyclooxygenase 2 Inhibitor Business (2016-2021)
11.7.5 Mylan Recent Development
11.8 Teva Pharmaceutical
11.8.1 Teva Pharmaceutical Company Details
11.8.2 Teva Pharmaceutical Business Overview
11.8.3 Teva Pharmaceutical Cyclooxygenase 2 Inhibitor Introduction
11.8.4 Teva Pharmaceutical Revenue in Cyclooxygenase 2 Inhibitor Business (2016-2021)
11.8.5 Teva Pharmaceutical Recent Development
11.9 Alembic Pharmaceutical
11.9.1 Alembic Pharmaceutical Company Details
11.9.2 Alembic Pharmaceutical Business Overview
11.9.3 Alembic Pharmaceutical Cyclooxygenase 2 Inhibitor Introduction
11.9.4 Alembic Pharmaceutical Revenue in Cyclooxygenase 2 Inhibitor Business (2016-2021)
11.9.5 Alembic Pharmaceutical Recent Development
11.10 Aurobindo Pharma
11.10.1 Aurobindo Pharma Company Details
11.10.2 Aurobindo Pharma Business Overview
11.10.3 Aurobindo Pharma Cyclooxygenase 2 Inhibitor Introduction
11.10.4 Aurobindo Pharma Revenue in Cyclooxygenase 2 Inhibitor Business (2016-2021)
11.10.5 Aurobindo Pharma Recent Development
11.11 Cipla
11.11.1 Cipla Company Details
11.11.2 Cipla Business Overview
11.11.3 Cipla Cyclooxygenase 2 Inhibitor Introduction
11.11.4 Cipla Revenue in Cyclooxygenase 2 Inhibitor Business (2016-2021)
11.11.5 Cipla Recent Development
11.12 Torrent Pharmaceuticals
11.12.1 Torrent Pharmaceuticals Company Details
11.12.2 Torrent Pharmaceuticals Business Overview
11.12.3 Torrent Pharmaceuticals Cyclooxygenase 2 Inhibitor Introduction
11.12.4 Torrent Pharmaceuticals Revenue in Cyclooxygenase 2 Inhibitor Business (2016-2021)
11.12.5 Torrent Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Figures, Tables and Charts Available in Global Cyclooxygenase 2 Inhibitor Market Size, Status and Forecast 2021-2027
List of TablesTable 1. Global Cyclooxygenase 2 Inhibitor Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Selective Cox 2 Inhibitor
Table 3. Key Players of Non-Selective Cox 2 Inhibitor
Table 4. Global Cyclooxygenase 2 Inhibitor Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Cyclooxygenase 2 Inhibitor Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Cyclooxygenase 2 Inhibitor Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Cyclooxygenase 2 Inhibitor Market Share by Regions (2016-2021)
Table 8. Global Cyclooxygenase 2 Inhibitor Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Cyclooxygenase 2 Inhibitor Market Share by Regions (2022-2027)
Table 10. Cyclooxygenase 2 Inhibitor Market Trends
Table 11. Cyclooxygenase 2 Inhibitor Market Drivers
Table 12. Cyclooxygenase 2 Inhibitor Market Challenges
Table 13. Cyclooxygenase 2 Inhibitor Market Restraints
Table 14. Global Cyclooxygenase 2 Inhibitor Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Cyclooxygenase 2 Inhibitor Market Share by Players (2016-2021)
Table 16. Global Top Cyclooxygenase 2 Inhibitor Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cyclooxygenase 2 Inhibitor as of 2020)
Table 17. Ranking of Global Top Cyclooxygenase 2 Inhibitor Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Cyclooxygenase 2 Inhibitor Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Cyclooxygenase 2 Inhibitor Product Solution and Service
Table 21. Date of Enter into Cyclooxygenase 2 Inhibitor Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Cyclooxygenase 2 Inhibitor Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Cyclooxygenase 2 Inhibitor Revenue Market Share by Type (2016-2021)
Table 25. Global Cyclooxygenase 2 Inhibitor Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Cyclooxygenase 2 Inhibitor Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Cyclooxygenase 2 Inhibitor Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Cyclooxygenase 2 Inhibitor Revenue Market Share by Application (2016-2021)
Table 29. Global Cyclooxygenase 2 Inhibitor Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Cyclooxygenase 2 Inhibitor Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Cyclooxygenase 2 Inhibitor Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Cyclooxygenase 2 Inhibitor Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Cyclooxygenase 2 Inhibitor Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Cyclooxygenase 2 Inhibitor Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Cyclooxygenase 2 Inhibitor Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Cyclooxygenase 2 Inhibitor Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Cyclooxygenase 2 Inhibitor Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Cyclooxygenase 2 Inhibitor Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Cyclooxygenase 2 Inhibitor Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Cyclooxygenase 2 Inhibitor Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Cyclooxygenase 2 Inhibitor Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Cyclooxygenase 2 Inhibitor Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Cyclooxygenase 2 Inhibitor Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Cyclooxygenase 2 Inhibitor Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Cyclooxygenase 2 Inhibitor Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Cyclooxygenase 2 Inhibitor Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Cyclooxygenase 2 Inhibitor Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Cyclooxygenase 2 Inhibitor Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Cyclooxygenase 2 Inhibitor Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Cyclooxygenase 2 Inhibitor Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Cyclooxygenase 2 Inhibitor Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Cyclooxygenase 2 Inhibitor Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Cyclooxygenase 2 Inhibitor Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Cyclooxygenase 2 Inhibitor Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Cyclooxygenase 2 Inhibitor Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Cyclooxygenase 2 Inhibitor Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Cyclooxygenase 2 Inhibitor Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Cyclooxygenase 2 Inhibitor Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Cyclooxygenase 2 Inhibitor Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Cyclooxygenase 2 Inhibitor Market Size by Country (2022-2027) & (US$ Million)
Table 61. Pfizer Company Details
Table 62. Pfizer Business Overview
Table 63. Pfizer Cyclooxygenase 2 Inhibitor Product
Table 64. Pfizer Revenue in Cyclooxygenase 2 Inhibitor Business (2016-2021) & (US$ Million)
Table 65. Pfizer Recent Development
Table 66. Bayer Company Details
Table 67. Bayer Business Overview
Table 68. Bayer Cyclooxygenase 2 Inhibitor Product
Table 69. Bayer Revenue in Cyclooxygenase 2 Inhibitor Business (2016-2021) & (US$ Million)
Table 70. Bayer Recent Development
Table 71. Novartis Company Details
Table 72. Novartis Business Overview
Table 73. Novartis Cyclooxygenase 2 Inhibitor Product
Table 74. Novartis Revenue in Cyclooxygenase 2 Inhibitor Business (2016-2021) & (US$ Million)
Table 75. Novartis Recent Development
Table 76. Merck Company Details
Table 77. Merck Business Overview
Table 78. Merck Cyclooxygenase 2 Inhibitor Product
Table 79. Merck Revenue in Cyclooxygenase 2 Inhibitor Business (2016-2021) & (US$ Million)
Table 80. Merck Recent Development
Table 81. Sabinsa Company Details
Table 82. Sabinsa Business Overview
Table 83. Sabinsa Cyclooxygenase 2 Inhibitor Product
Table 84. Sabinsa Revenue in Cyclooxygenase 2 Inhibitor Business (2016-2021) & (US$ Million)
Table 85. Sabinsa Recent Development
Table 86. Cadila Pharmaceuticals Company Details
Table 87. Cadila Pharmaceuticals Business Overview
Table 88. Cadila Pharmaceuticals Cyclooxygenase 2 Inhibitor Product
Table 89. Cadila Pharmaceuticals Revenue in Cyclooxygenase 2 Inhibitor Business (2016-2021) & (US$ Million)
Table 90. Cadila Pharmaceuticals Recent Development
Table 91. Mylan Company Details
Table 92. Mylan Business Overview
Table 93. Mylan Cyclooxygenase 2 Inhibitor Product
Table 94. Mylan Revenue in Cyclooxygenase 2 Inhibitor Business (2016-2021) & (US$ Million)
Table 95. Mylan Recent Development
Table 96. Teva Pharmaceutical Company Details
Table 97. Teva Pharmaceutical Business Overview
Table 98. Teva Pharmaceutical Revenue in Cyclooxygenase 2 Inhibitor Business (2016-2021) & (US$ Million)
Table 99. Teva Pharmaceutical Recent Development
Table 100. Alembic Pharmaceutical Company Details
Table 101. Alembic Pharmaceutical Business Overview
Table 102. Alembic Pharmaceutical Cyclooxygenase 2 Inhibitor Product
Table 103. Alembic Pharmaceutical Revenue in Cyclooxygenase 2 Inhibitor Business (2016-2021) & (US$ Million)
Table 104. Alembic Pharmaceutical Recent Development
Table 105. Aurobindo Pharma Company Details
Table 106. Aurobindo Pharma Business Overview
Table 107. Aurobindo Pharma Cyclooxygenase 2 Inhibitor Product
Table 108. Aurobindo Pharma Revenue in Cyclooxygenase 2 Inhibitor Business (2016-2021) & (US$ Million)
Table 109. Aurobindo Pharma Recent Development
Table 110. Cipla Company Details
Table 111. Cipla Business Overview
Table 112. Cipla Cyclooxygenase 2 Inhibitor Product
Table 113. Cipla Revenue in Cyclooxygenase 2 Inhibitor Business (2016-2021) & (US$ Million)
Table 114. Cipla Recent Development
Table 115. Torrent Pharmaceuticals Company Details
Table 116. Torrent Pharmaceuticals Business Overview
Table 117. Torrent Pharmaceuticals Cyclooxygenase 2 Inhibitor Product
Table 118. Torrent Pharmaceuticals Revenue in Cyclooxygenase 2 Inhibitor Business (2016-2021) & (US$ Million)
Table 119. Torrent Pharmaceuticals Recent Development
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cyclooxygenase 2 Inhibitor Market Share by Type: 2020 VS 2027
Figure 2. Selective Cox 2 Inhibitor Features
Figure 3. Non-Selective Cox 2 Inhibitor Features
Figure 4. Global Cyclooxygenase 2 Inhibitor Market Share by Application: 2020 VS 2027
Figure 5. Hospital Case Studies
Figure 6. Specialty Clinic Case Studies
Figure 7. Others Case Studies
Figure 8. Cyclooxygenase 2 Inhibitor Report Years Considered
Figure 9. Global Cyclooxygenase 2 Inhibitor Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Cyclooxygenase 2 Inhibitor Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Cyclooxygenase 2 Inhibitor Market Share by Regions: 2020 VS 2027
Figure 12. Global Cyclooxygenase 2 Inhibitor Market Share by Regions (2022-2027)
Figure 13. Global Cyclooxygenase 2 Inhibitor Market Share by Players in 2020
Figure 14. Global Top Cyclooxygenase 2 Inhibitor Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cyclooxygenase 2 Inhibitor as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Cyclooxygenase 2 Inhibitor Revenue in 2020
Figure 16. Global Cyclooxygenase 2 Inhibitor Revenue Market Share by Type (2016-2021)
Figure 17. Global Cyclooxygenase 2 Inhibitor Revenue Market Share by Type (2022-2027)
Figure 18. North America Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Cyclooxygenase 2 Inhibitor Market Share by Type (2016-2027)
Figure 20. North America Cyclooxygenase 2 Inhibitor Market Share by Application (2016-2027)
Figure 21. North America Cyclooxygenase 2 Inhibitor Market Share by Country (2016-2027)
Figure 22. United States Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Cyclooxygenase 2 Inhibitor Market Share by Type (2016-2027)
Figure 26. Europe Cyclooxygenase 2 Inhibitor Market Share by Application (2016-2027)
Figure 27. Europe Cyclooxygenase 2 Inhibitor Market Share by Country (2016-2027)
Figure 28. Germany Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Cyclooxygenase 2 Inhibitor Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Cyclooxygenase 2 Inhibitor Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Cyclooxygenase 2 Inhibitor Market Share by Region (2016-2027)
Figure 38. China Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Cyclooxygenase 2 Inhibitor Market Share by Type (2016-2027)
Figure 46. Latin America Cyclooxygenase 2 Inhibitor Market Share by Application (2016-2027)
Figure 47. Latin America Cyclooxygenase 2 Inhibitor Market Share by Country (2016-2027)
Figure 48. Mexico Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Cyclooxygenase 2 Inhibitor Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Cyclooxygenase 2 Inhibitor Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Cyclooxygenase 2 Inhibitor Market Share by Country (2016-2027)
Figure 54. Turkey Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Pfizer Revenue Growth Rate in Cyclooxygenase 2 Inhibitor Business (2016-2021)
Figure 58. Bayer Revenue Growth Rate in Cyclooxygenase 2 Inhibitor Business (2016-2021)
Figure 59. Novartis Revenue Growth Rate in Cyclooxygenase 2 Inhibitor Business (2016-2021)
Figure 60. Merck Revenue Growth Rate in Cyclooxygenase 2 Inhibitor Business (2016-2021)
Figure 61. Sabinsa Revenue Growth Rate in Cyclooxygenase 2 Inhibitor Business (2016-2021)
Figure 62. Cadila Pharmaceuticals Revenue Growth Rate in Cyclooxygenase 2 Inhibitor Business (2016-2021)
Figure 63. Mylan Revenue Growth Rate in Cyclooxygenase 2 Inhibitor Business (2016-2021)
Figure 64. Teva Pharmaceutical Revenue Growth Rate in Cyclooxygenase 2 Inhibitor Business (2016-2021)
Figure 65. Alembic Pharmaceutical Revenue Growth Rate in Cyclooxygenase 2 Inhibitor Business (2016-2021)
Figure 66. Aurobindo Pharma Revenue Growth Rate in Cyclooxygenase 2 Inhibitor Business (2016-2021)
Figure 67. Cipla Revenue Growth Rate in Cyclooxygenase 2 Inhibitor Business (2016-2021)
Figure 68. Torrent Pharmaceuticals Revenue Growth Rate in Cyclooxygenase 2 Inhibitor Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
Keyplayers in Global Cyclooxygenase 2 Inhibitor Market Size, Status and Forecast 2021-2027
PfizerBayer
Novartis
Merck
Sabinsa
Cadila Pharmaceuticals
Mylan
Teva Pharmaceutical
Alembic Pharmaceutical
Aurobindo Pharma
Cipla
Torrent Pharmaceuticals
Request Sample
Request Discount
